Filing Details
- Accession Number:
- 0001209191-14-034291
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-15 17:08:30
- Reporting Period:
- 2014-05-13
- Filing Date:
- 2014-05-15
- Accepted Time:
- 2014-05-15 17:08:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1600049 | Gary Bridger | C/O Five Corners Capital 700 W. Georgia Street, Suite 2500 Vancouver A1 V7Y 1B3 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-13 | 3,219,528 | $0.00 | 3,219,528 | No | 4 | C | Indirect | By Ventures West 8 Limited Partnership |
Common Stock | Acquisiton | 2014-05-13 | 250,000 | $10.00 | 3,469,528 | No | 4 | P | Indirect | By Ventures West 8 Limited Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Ventures West 8 Limited Partnership |
No | 4 | P | Indirect | By Ventures West 8 Limited Partnership |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2014-05-13 | 1,027,668 | $0.00 | 1,027,668 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-05-13 | 853,146 | $0.00 | 853,146 | $0.00 |
Common Stock | Series C Preferred Stock | Disposition | 2014-05-13 | 841,750 | $0.00 | 841,750 | $0.00 |
Common Stock | Series D Preferred Stock | Disposition | 2014-05-13 | 496,964 | $0.00 | 496,964 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The preferred stock converted into common stock upon the closing of the issuer's initial public offering on a 1-for-1 basis and had no expiration date.
- Dr. Bridger is a managing director of Five Corners Capital Inc., the general partner of Ventures West 8 Limited Partnership. Dr. Bridger may be deemed to hold voting and investment power with respect to shares held by Ventures West 8 Limited Partnership. Dr. Bridger disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.